VEGF 165 (Active) 蛋白
-
- 抗原
- VEGF 165
- 蛋白类型
- Recombinant
- 生物活性
- Active
-
宿主
- 人
-
资源
- 大肠杆菌(E. Coli)
- 应用范围
- SDS-PAGE (SDS)
- 原理
- VEGF 165 (human) (rec.)
- 交叉反应
- 人
- 产品特性
- Human VEGF 165 (165aa).
- 纯度
- >95 % (SDS-PAGE)
- 内毒素水平
- <0.1ng/μg protein.
- Biological Activity Comment
- The ED50 for stimulation of cell proliferation in human umbilical vein endothelial cells by VEGF 165 has been determined to be in the range of 1-5ng/ml.
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Reconstitute with 50 mM acetic acid to a concentration not lower than 50 μg/mL.
- 注意事项
- After reconstitution, prepare aliquots and store at -20 °C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. For long term storage we recommend to add at least 0.1 % human or bovine serum albumin.
- 储存条件
- 4 °C,-20 °C
- 储存方法
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Use & Stability: Stable for at least 6 months after receipt when stored at -20°C.
- 有效期
- 6 months
-
- 抗原
- VEGF 165
- 背景
-
Vascular Endothelial Growth Factor, VEGF-A, VPF
Human vascular endothelial growth factor (VEGF 165) is produced as a homodimer. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. VEGF 165 is a specific mitogen for vascular endothelial cells and a strong angiogenic factor in vivo. In addition to its action as a mitogen it is a potent vascular permeability factor (VPF) in vivo. It is also a chemoattractant molecule for monocytes and endothelial cells. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
- 分子量
- ~38.2kDa
- UniProt
- P15692-4
-